SARS-CoV-2 alpha variant exhibits enhanced household transmission

Household transmission remains a major driver in the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout communities worldwide. While a number of reports have described the intra-household transmission of SARS-CoV-2, few have compared transmission rates between SARS-CoV-2 variants of concern (VoCs) in this setting.

In a paper recently published on the preprint server medRxiv*, the transmission rate of wildtype and the Alpha variant of SARS-CoV-2 through households is tracked. In this study, the researchers find that the risk of secondary infections is significantly heightened amongst residents with VoCs.

Study: Household transmission of SARS-CoV-2 in Norway; a prospective, longitudinal study showing increased transmissibility of the Alpha variant (B.1.1.7) compared with other variants. Image Credit: Evegeny Atamanenko / Shutterstock.com

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

How was the study performed?

Sixty-five households in Norway with confirmed coronavirus disease 2019 (COVID-19) cases by reverse-transcriptase polymerase chain reaction (RT-PCR) between May 2020 and May 2021 were included in the study. Participants were refined to fit the following criteria, in which only one person who was at least 12 years old in the household had initially tested positive for COVID-19. Additionally, no other individuals in the house were vaccinated.

Each of the selected households was visited eight times for oropharyngeal and saliva sample collection over six weeks. These samples were subsequently tested for SARS-CoV-2 by RT-PCR, with positive samples sent for further immunological analyses to identify the virus lineage.

Questionnaires related to the household were also completed by each participant. These surveys included a wide range of questions on COVID-19 risk factors, both medical and behavioral. Survey participants were also asked to describe any quarantine precautions that they or other individuals within the household had undertaken.

Of the 65 primary COVID-19 cases included in the study, 18 were found to be positive for the Alpha variant, one for the beta variant, and the remaining positive for either the wildtype strain or another non-VoC. Notably, all Alpha variant cases were recruited in the latter months of the study, thus reflecting the changing viral population in the community over the course of the pandemic as the more highly transmissible Alpha strain became dominant.

In every reported case where initially non-infected household members contracted COVID-19 during the study, the specific genetic lineage was found to match that of the primary case. It is therefore likely that the majority of these infections originated from within the household.

The group also note that the average age of primary cases was greater than amongst secondary cases, 38 years compared to 24 years. It should be noted that this observation is likely an artifact of study design, as secondary but not primary cases aged 3-11 years old were included.

Differences in household transmission between SARS-CoV-2 variants

In total, 200 participants who were divided among 65 households were involved in the study, of which 132 individuals (66%) eventually became infected. Of those infected, almost half had mild or moderate symptoms, with just 14% being asymptomatic at two weeks post-infection.

Children were more likely to be asymptomatic than adults. Additionally, a higher percentage of asymptomatic cases were reported amongst those with the Alpha variant (22%) as compared to any other non-VoC (9%).

The authors found that secondary transmission occurred in 60% of all households included in the study. Approximately half of all initially non-infected individuals contracted SARS-CoV-2 during the six-week course of testing.

Upon differentiating between households with the Alpha variant, the authors of the current study found that secondary transmission occurred in 83.3% of Alpha-households, as compared to 55% of households who tested positive with other strains of SARS-CoV-2. Similarly, 77.8% of initially uninfected individuals in Alpha lineage households became infected, while only 42.5% of individuals became infected in non-VoC households.

The authors of the current study discount a number of factors as irrelevant to transmission rates within the study. Moreover, no discernible difference based on sex or blood type was observed, though older adults were more likely to become infected.

Household size was also disregarded as a major factor. Although “overcrowded” houses tended to bear a greater infection risk between individuals, this was often offset by the smaller number of individuals sharing such a space.

Overall, no difference was noted in secondary transmissions relating to the type of house, house size, or the number of bathrooms. There was, however, a trend towards more probable transmission if the household members shared a toilet, came into touch contact often and shared a bed with the primary case before infection was noted.

The only household-based non-pharmaceutical intervention that was found to be efficacious was avoiding bed-sharing. To this end, 38% of those who slept separately contracted SARS-CoV-2, as compared with 67% of bed-sharers.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Apr 12 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Michael Greenwood

Written by

Michael Greenwood

Michael graduated from the University of Salford with a Ph.D. in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Greenwood, Michael. (2023, April 12). SARS-CoV-2 alpha variant exhibits enhanced household transmission. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20210823/SARS-CoV-2-alpha-variant-exhibits-enhanced-household-transmission.aspx.

  • MLA

    Greenwood, Michael. "SARS-CoV-2 alpha variant exhibits enhanced household transmission". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20210823/SARS-CoV-2-alpha-variant-exhibits-enhanced-household-transmission.aspx>.

  • Chicago

    Greenwood, Michael. "SARS-CoV-2 alpha variant exhibits enhanced household transmission". News-Medical. https://www.news-medical.net/news/20210823/SARS-CoV-2-alpha-variant-exhibits-enhanced-household-transmission.aspx. (accessed November 22, 2024).

  • Harvard

    Greenwood, Michael. 2023. SARS-CoV-2 alpha variant exhibits enhanced household transmission. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20210823/SARS-CoV-2-alpha-variant-exhibits-enhanced-household-transmission.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients